VISEN Pharmaceuticals (HKG:2561)
Hong Kong · Delayed Price · Currency is HKD 21.90
-1.04 (-4.53%)
Jun 1, 2026, 4:08 PM HKT
VISEN Pharmaceuticals Revenue
In the year 2025, VISEN Pharmaceuticals had annual revenue of 136.00K CNY, down -95.10%. VISEN Pharmaceuticals had revenue of -751.00K in the half year ending December 31, 2025.
Revenue
136.00K CNY
Revenue Growth
-95.10%
P/S Ratio
16,527.28
Revenue / Employee
1.66K CNY
Employees
82
Market Cap
2.50B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 136.00K | -2.64M | -95.10% |
| Dec 31, 2024 | 2.78M | 4.45M | - |
| Dec 31, 2023 | -1.67M | 629.00K | - |
| Dec 31, 2022 | -2.30M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition